Fund comparison · from official SEC filings

BIB vs PBE: how much do they overlap?

ProShares Ultra Nasdaq Biotechnology and Invesco Biotechnology & Genome ETF
Holdings overlap
26%
of assets, by weight
Shared positions
25
of 259 / 33 holdings
BIB expense ratio
0.95%
net, per year
PBE expense ratio
0.58%
net, per year
Shared holdings
Company
BIB
PBE
U
UTHRUNITED THERAPEUTICS CORP
1.36%
5.45%
G
GILDGILEAD SCIENCES INC
5.19%
4.00%
A
AMGNAMGEN INC
4.99%
4.09%
I
ILMNILLUMINA INC
1.39%
4.66%
B
BIIBBIOGEN INC
1.61%
4.38%
I
INCYINCYTE CORP
1.08%
4.26%
A
ALNYALNYLAM PHARMACEUTICALS INC
2.24%
4.20%
R
REGNREGENERON PHARMACEUTICALS
3.57%
4.14%
B
BCRXBIOCRYST PHARMACEUTICALS INC
0.12%
2.97%
A
ARWRARROWHEAD PHARMACEUTICALS IN
0.61%
2.84%
P
PTGXPROTAGONIST THERAPEUTICS INC
0.36%
2.79%
R
RPRXROYALTY PHARMA PLC- CL A
1.34%
2.72%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.89%
2.48%
E
EXELEXELIXIS INC
0.73%
2.43%
P
PTCTPTC THERAPEUTICS INC
0.34%
2.32%
V
VCYTVERACYTE INC
0.21%
2.27%
A
ACAACADIA PHARMACEUTICALS INC
0.21%
2.25%
V
VCELVERICEL CORP
0.09%
2.24%
H
HALOHALOZYME THERAPEUTICS INC
0.44%
2.23%
T
TBPHTHERAVANCE BIOPHARMA INC
0.05%
2.16%
I
IONSIONIS PHARMACEUTICALS INC
0.71%
2.16%
B
BMRNBIOMARIN PHARMACEUTICAL INC
0.62%
2.12%
C
COLLCOLLEGIUM PHARMACEUTICAL INC
0.06%
1.84%
M
MNKDMANNKIND CORP
0.06%
1.26%
A
AGPXXINVESCO GVT & AGNCY-INST
0.90%
0.05%
Only in BIB
?
N/A
17.83%
I
IQMMPROSHARES GENIUS MNY MKT ETF
7.57%
V
VRTXVERTEX PHARMACEUTICALS INC
5.18%
?
Repurchase Agreement
3.50%
R
RVMDREVOLUTION MEDICINES INC
1.74%
A
ARGXARGENX SE - ADR
1.33%
I
INSMINSMED INC
1.29%
R
ROIVROIVANT SCIENCES LTD
1.20%
V
VTRSVIATRIS INC
1.05%
M
MRNAMODERNA INC
1.04%
G
GHGUARDANT HEALTH INC
0.95%
J
JAZZJAZZ PHARMACEUTICALS PLC
0.81%
A
ASNDASCENDIS PHARMA A/S
0.77%
S
SMMTSUMMIT THERAPEUTICS INC
0.76%
B
BBIOBRIDGEBIO PHARMA INC
0.72%
M
MEDPMEDPACE HOLDINGS INC
0.71%
A
AXSMAXSOME THERAPEUTICS INC
0.67%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.64%
B
BNTXBIONTECH SE-ADR
0.61%
S
SNYSANOFI-ADR
0.60%
P
PRAXPRAXIS PRECISION MEDICINES I
0.54%
C
CYTKCYTOKINETICS INC
0.53%
O
ONCBEONE MEDICINES LTD-ADR
0.51%
K
KRYSKRYSTAL BIOTECH INC
0.50%
T
TEMTEMPUS AI INC-CL A
0.49%
Only in PBE
?
Invesco Private Prime Fund
9.47%
?
Invesco Private Government Fund
3.65%
?
CATALYST PHARMACEUTICALS, INC.
2.87%
T
TGTXTG THERAPEUTICS INC
2.73%
C
CDNACAREDX INC
2.66%
T
TECHBIO-TECHNE CORP
2.37%
R
RGENREPLIGEN CORP
2.17%
Q
QGENQIAGEN N.V.
1.76%
Hold BIB and PBE together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.